Market Cap 785.41M
Revenue (ttm) 294.28M
Net Income (ttm) 367.02M
EPS (ttm) N/A
PE Ratio 10.86
Forward PE 14.80
Profit Margin 124.72%
Debt to Equity Ratio 0.00
Volume 267,300
Avg Vol 355,832
Day's Range N/A - N/A
Shares Out 18.50M
Stochastic %K 98%
Beta 1.16
Analysts Sell
Price Target $61.20

Company Profile

Rigel Pharmaceuticals, Inc., a biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States. The company offers TAVALISSE, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; REZLIDHIA, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (I...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 624 1100
Fax: 650 624 1101
Address:
611 Gateway Boulevard, Suite 900, South San Francisco, United States
Flainbrain
Flainbrain Aug. 19 at 2:16 PM
0 · Reply
MaxKlim
MaxKlim Aug. 19 at 1:53 PM
$RIGL 45,5$ please 🙏🏻
0 · Reply
B4I4QQTRU18
B4I4QQTRU18 Aug. 18 at 10:36 PM
$RIGL After hours.
1 · Reply
tobeme100
tobeme100 Aug. 18 at 7:51 PM
$RIGL last 10'...
0 · Reply
Berakhot
Berakhot Aug. 18 at 5:38 PM
$RIGL $43.33 :) .... keep on climbing boyzzzz
1 · Reply
tobeme100
tobeme100 Aug. 18 at 4:24 PM
$RIGL Love the quiet board!
0 · Reply
MaxKlim
MaxKlim Aug. 18 at 1:48 PM
$RIGL what happened? Stock stopped ?
2 · Reply
MaxKlim
MaxKlim Aug. 17 at 8:04 PM
$RIGL if there was no good news about a target hike, the greens would close
0 · Reply
Gabriel1234
Gabriel1234 Aug. 17 at 5:09 PM
$RIGL Check out RIGL $42.X,46 on TipRanks https://tipranks.onelink.me/WJho/b7rvmm0k
0 · Reply
Gabriel1234
Gabriel1234 Aug. 17 at 5:09 PM
$RIGL https://tipranks.onelink.me/WJho/zqxzycrw
0 · Reply
Latest News on RIGL
Rigel Pharmaceuticals Earnings Call Transcript: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 14 days ago

Rigel Pharmaceuticals Earnings Call Transcript: Q2 2026


Rigel Pharmaceuticals Earnings release: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 14 days ago

Rigel Pharmaceuticals Earnings release: Q2 2026


Rigel Pharmaceuticals Quarterly report: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 14 days ago

Rigel Pharmaceuticals Quarterly report: Q2 2026


Rigel Pharmaceuticals Slides: Q2 2026

Aug 4, 2026, 4:30 PM EDT - 14 days ago

Rigel Pharmaceuticals Slides: Q2 2026


Rigel Pharmaceuticals reports Q2 EPS 88c, consensus (8c)

2026-08-04T20:25:43.000Z - 14 days ago

Rigel Pharmaceuticals reports Q2 EPS 88c, consensus (8c)


Rigel Reports Second Quarter 2026 Financial Results

Aug 4, 2026, 4:01 PM EDT - 14 days ago

Rigel Reports Second Quarter 2026 Financial Results


Rigel Pharmaceuticals Slides: Corporate presentation

Aug 4, 2026, 9:00 AM EDT - 15 days ago

Rigel Pharmaceuticals Slides: Corporate presentation


Rigel Appoints Board Member Alison L. Hannah, M.D.

Jul 1, 2026, 8:05 AM EDT - 7 weeks ago

Rigel Appoints Board Member Alison L. Hannah, M.D.


Rigel closes license agreement for Veppanu

2026-06-16T20:13:09.000Z - 2 months ago

Rigel closes license agreement for Veppanu

ARVN PFE


Rigel Pharmaceuticals Slides: Corporate presentation

Jun 16, 2026, 7:00 AM EDT - 2 months ago

Rigel Pharmaceuticals Slides: Corporate presentation


Rigel to Present at the Jefferies Global Healthcare Conference

May 27, 2026, 8:05 AM EDT - 3 months ago

Rigel to Present at the Jefferies Global Healthcare Conference


Rigel Pharmaceuticals Transcript: Investor update

May 12, 2026, 8:00 AM EDT - 3 months ago

Rigel Pharmaceuticals Transcript: Investor update


Rigel Pharmaceuticals Press release: Investor update

May 12, 2026, 8:00 AM EDT - 3 months ago

Rigel Pharmaceuticals Press release: Investor update


Rigel Pharmaceuticals Slides: Corporate presentation

May 12, 2026, 2:00 AM EDT - 3 months ago

Rigel Pharmaceuticals Slides: Corporate presentation


Rigel Pharmaceuticals Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Rigel Pharmaceuticals Earnings Call Transcript: Q1 2026


Rigel Pharmaceuticals Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Rigel Pharmaceuticals Quarterly report: Q1 2026


Rigel Pharmaceuticals Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Rigel Pharmaceuticals Earnings release: Q1 2026


Rigel Pharmaceuticals Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Rigel Pharmaceuticals Slides: Q1 2026


Rigel Pharmaceuticals reports Q1 EPS 44c, consensus 87c

2026-05-05T20:07:48.000Z - 3 months ago

Rigel Pharmaceuticals reports Q1 EPS 44c, consensus 87c


Rigel Reports First Quarter 2026 Financial Results

May 5, 2026, 4:01 PM EDT - 3 months ago

Rigel Reports First Quarter 2026 Financial Results


Rigel Pharmaceuticals Slides: Corporate presentation

May 5, 2026, 7:00 AM EDT - 3 months ago

Rigel Pharmaceuticals Slides: Corporate presentation


Rigel Pharmaceuticals Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Rigel Pharmaceuticals Proxy statement: Proxy filing


Rigel Pharmaceuticals Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 4 months ago

Rigel Pharmaceuticals Proxy statement: Proxy filing


Rigel Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 3, 2026, 4:30 PM EST - 6 months ago

Rigel Pharmaceuticals Earnings Call Transcript: Q4 2025


Rigel Pharmaceuticals Annual report: Q4 2025

Mar 3, 2026, 4:30 PM EST - 6 months ago

Rigel Pharmaceuticals Annual report: Q4 2025


Rigel Pharmaceuticals Earnings release: Q4 2025

Mar 3, 2026, 4:30 PM EST - 6 months ago

Rigel Pharmaceuticals Earnings release: Q4 2025


Rigel Pharmaceuticals Slides: Q4 2025

Mar 3, 2026, 4:30 PM EST - 6 months ago

Rigel Pharmaceuticals Slides: Q4 2025


Rigel Appoints Michael P. Miller to the Board of Directors

Feb 3, 2026, 8:05 AM EST - 7 months ago

Rigel Appoints Michael P. Miller to the Board of Directors


Rigel Provides Business Update and 2026 Outlook

Jan 12, 2026, 8:05 AM EST - 7 months ago

Rigel Provides Business Update and 2026 Outlook


Rigel Pharmaceuticals Slides: Corporate presentation

Jan 12, 2026, 7:00 AM EST - 7 months ago

Rigel Pharmaceuticals Slides: Corporate presentation


Rigel Pharmaceuticals Slides: Corporate Presentation

Dec 7, 2025, 7:00 AM EST - 9 months ago

Rigel Pharmaceuticals Slides: Corporate Presentation


Rigel Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

Rigel Pharmaceuticals Earnings Call Transcript: Q3 2025


Rigel Pharmaceuticals Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

Rigel Pharmaceuticals Earnings release: Q3 2025


Rigel Pharmaceuticals Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

Rigel Pharmaceuticals Quarterly report: Q3 2025


Rigel Pharmaceuticals Slides: Q3 2025

Nov 4, 2025, 4:30 PM EST - 10 months ago

Rigel Pharmaceuticals Slides: Q3 2025


Overlooked Stock: RIGL Nearly Doubles Stock in August

Aug 15, 2025, 5:20 PM EDT - 1 year ago

Overlooked Stock: RIGL Nearly Doubles Stock in August


The Big 3: OPEN, RIGL, JOBY

Aug 15, 2025, 12:00 PM EDT - 1 year ago

The Big 3: OPEN, RIGL, JOBY

JOBY OPEN


Rigel Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Earnings Call Transcript: Q2 2025


Rigel Pharmaceuticals Quarterly report: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Quarterly report: Q2 2025


Rigel Pharmaceuticals Earnings release: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Earnings release: Q2 2025


Rigel Pharmaceuticals Slides: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Slides: Q2 2025


Rigel Pharmaceuticals Earnings Call Transcript: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Earnings Call Transcript: Q1 2025


Rigel Pharmaceuticals Earnings release: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Earnings release: Q1 2025


Rigel Pharmaceuticals Quarterly report: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Quarterly report: Q1 2025


Rigel Pharmaceuticals Slides: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Rigel Pharmaceuticals Slides: Q1 2025


Rigel Pharmaceuticals Slides: Investor Presentation

May 6, 2025, 7:00 AM EDT - 1 year ago

Rigel Pharmaceuticals Slides: Investor Presentation


Rigel Pharmaceuticals Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Rigel Pharmaceuticals Proxy statement: Proxy Filing


Rigel Pharmaceuticals Proxy statement: Proxy Filing

Apr 10, 2025, 8:00 AM EDT - 1 year ago

Rigel Pharmaceuticals Proxy statement: Proxy Filing


Rigel Appoints Mark W. Frohlich, M.D.

Mar 10, 2025, 8:05 AM EDT - 1 year ago

Rigel Appoints Mark W. Frohlich, M.D.


Rigel Pharmaceuticals Earnings Call Transcript: Q4 2024

Mar 4, 2025, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Earnings Call Transcript: Q4 2024


Rigel Pharmaceuticals Earnings release: Q4 2024

Mar 4, 2025, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Earnings release: Q4 2024


Rigel Pharmaceuticals Annual report: Q4 2024

Mar 4, 2025, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Annual report: Q4 2024


Rigel Pharmaceuticals Slides: Q4 2024

Mar 4, 2025, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Slides: Q4 2024


Rigel Pharmaceuticals Slides: FY 2025

Jan 16, 2025, 11:15 AM EST - 1 year ago

Rigel Pharmaceuticals Slides: FY 2025


Rigel Provides Business Update and 2025 Outlook

Jan 13, 2025, 8:05 AM EST - 1 year ago

Rigel Provides Business Update and 2025 Outlook


Rigel Pharmaceuticals Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Earnings Call Transcript: Q3 2024


Rigel Pharmaceuticals Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Earnings release: Q3 2024


Rigel Pharmaceuticals Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Quarterly report: Q3 2024


Rigel Pharmaceuticals Slides: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Rigel Pharmaceuticals Slides: Q3 2024


Flainbrain
Flainbrain Aug. 19 at 2:16 PM
0 · Reply
MaxKlim
MaxKlim Aug. 19 at 1:53 PM
$RIGL 45,5$ please 🙏🏻
0 · Reply
B4I4QQTRU18
B4I4QQTRU18 Aug. 18 at 10:36 PM
$RIGL After hours.
1 · Reply
tobeme100
tobeme100 Aug. 18 at 7:51 PM
$RIGL last 10'...
0 · Reply
Berakhot
Berakhot Aug. 18 at 5:38 PM
$RIGL $43.33 :) .... keep on climbing boyzzzz
1 · Reply
tobeme100
tobeme100 Aug. 18 at 4:24 PM
$RIGL Love the quiet board!
0 · Reply
MaxKlim
MaxKlim Aug. 18 at 1:48 PM
$RIGL what happened? Stock stopped ?
2 · Reply
MaxKlim
MaxKlim Aug. 17 at 8:04 PM
$RIGL if there was no good news about a target hike, the greens would close
0 · Reply
Gabriel1234
Gabriel1234 Aug. 17 at 5:09 PM
$RIGL Check out RIGL $42.X,46 on TipRanks https://tipranks.onelink.me/WJho/b7rvmm0k
0 · Reply
Gabriel1234
Gabriel1234 Aug. 17 at 5:09 PM
$RIGL https://tipranks.onelink.me/WJho/zqxzycrw
0 · Reply
Gabriel1234
Gabriel1234 Aug. 17 at 4:39 PM
$RIGL https://www.gurufocus.com/news/9038880/rigl-maintains-neutral-rating-price-target-raised-to-4900-by-piper-sandler?utm_source=marketwatch&utm_medium=syndication&utm_campaign=headlines&r=4bf001661e6fdd88d0cd7a5659ff9748&mod=mw_quote_news
1 · Reply
JR603
JR603 Aug. 16 at 6:50 PM
$RIGL Across the two 2026 notes, H.C. Wainwright raises its Rigel Pharmaceuticals price target from US$57 to US$85, linking the higher figure to both Veppanu in the U.S. and Rezlidhia under the Kissei agreement.
3 · Reply
Gabriel1234
Gabriel1234 Aug. 16 at 6:32 PM
$RIGL https://www.tipranks.com/news/the-fly/rigel-pharmaceuticals-price-target-raised-to-85-from-57-at-h-c-wainwright-thefly-news?mod=mw_quote_news
0 · Reply
biid
biid Aug. 14 at 11:33 PM
$RIGL https://finance.yahoo.com/healthcare/articles/capricor-therapeutics-shares-surge-98-120747174.html "Rigel priced a 30-day supply [of VEPPANU] at $29,400." That's $980 per day per patient.
0 · Reply
tobeme100
tobeme100 Aug. 14 at 7:44 PM
$RIGL I dare it to break 43.
1 · Reply
agilani2003
agilani2003 Aug. 14 at 7:12 PM
$RIGL RIGL upgraded by H.C.Wainwright. Price target raised from $57 to $85. It should already be near that price if not higher. IMO
0 · Reply
DBales26
DBales26 Aug. 14 at 5:12 PM
$RIGL Rigel's top 7 shareholders (Blackrock, Soleus, Armistice, State Street, Vanguard, American Century Companies, and LSV Asset Management) plus insiders now own 52.2% of the company. That's insane to think about, especially considering how much they loaded up in Q2 this year, and how much they knocked out retail who now own ~1.25% of Rigel. These groups and insiders are now in control here with whatever comes next.
4 · Reply
Gabriel1234
Gabriel1234 Aug. 14 at 3:46 PM
$RIGL https://tipranks.onelink.me/WJho/qr762jhc
0 · Reply
Namhguab
Namhguab Aug. 14 at 2:10 PM
$RIGL The more I read on Protacs, the more exciting this next couple years is going to be here. Very interesting stuff they are doing and it’s a huge step forward for them. IMO
0 · Reply
Massimo21
Massimo21 Aug. 14 at 1:36 PM
$RIGL Vepdegestrant demonstrated signs of preliminary antitumor activity in heavily pretreated Chinese patients with ER+/HER2- advanced breast cancer. https://pubmed.ncbi.nlm.nih.gov/42593688/
0 · Reply
Ou8mycookie
Ou8mycookie Aug. 14 at 12:29 PM
$RIGL remember these are heavily pretreated patients. Most out of other options.
1 · Reply
GO_DAWGS
GO_DAWGS Aug. 14 at 9:44 AM
$RIGL 98.69% … not sure how anyone owns any here if you add in Insider Ownership?
1 · Reply